distant metastatic recurrence, hence; FDG-PET/CT should be used as a first priority in patients with steadily rising serum CA 15-3 levels, or with clinical/ radiologic suspicion of recurrence.
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ABSTRACT:
After initial treatment of breast cancer; Conclusion: Our results indicated that PET/CT is the most sensitive and accurate tool for follow-up of breast cancer patients presenting with clinical, laboratory and/or radiologic suspicion of loco-regional or
INTRODUCTION:
Breast cancer is recognized as the most leading cause of death in women worldwide, with progressively increased incidence over the last few decades. 
PATIENTS AND METHODS:
We performed whole body 18F FDG-PET/CT on 37 patients with breast cancer with clinical, laboratory and/or radiologic suspicion of loco-regional or distant 
RESULTS:
We Eleven patients were referred with suspicious local breast recurrence; ten of them were correctly assigned by PET/CT as local recurrences. One case was correctly excluded by PET/CT (Figure 1 ).
Twenty five patients were presenting with suspicious nodal metastatic recurrence, twenty one of them were correctly assigned by PET/CT as nodal recurrences.
Three cases were correctly excluded by PET/CT.
One patient had false positive result by PET/CT as nodal recurrence. (Table 1) and (Figure 2 ).
Twenty two patients were presenting with suspicious osseous metastatic lesions.
Nineteen patients were correctly assigned by PET/CT as osseous metastases.
Two patients were correctly excluded to have bone metastasis by PET/CT. The last patient was identified by PET/CT as metastatic (Figure 3 & 4 Pathological examination of the symphesis menti lesion reported: Fibrous dysplasia.
The overall ( 
DISCUSSION:
Current In our study, eleven patients were presenting with suspicious local breast recurrence, ten of them were correctly assigned by PET/CT as local recurrences.
One case was correctly excluded by PET/CT and proved to be post-operative scarring (Figure 1) . In our study, twenty two patients were presenting with suspicious osseous metastatic recurrence. Nineteen patients were correctly assigned by PET/CT as osseous metastases (Figure 3) .
Two cases were correctly excluded by PET/CT and proved to be benign in nature.
The last case was mistakenly identified by PET/CT as metastatic and proved by pathologic examination to be fibrous dysplasia (Figure 4) .
Twelve patients were presenting with suspicious pulmonary metastatic recurrence.
Ten patients, with sub-cm to supra-cm pulmonary nodules, were correctly Six patients were presenting with suspicious hepatic metastatic recurrence.
In four patients lesions were correctly assigned by PET/CT as hepatic metastases. In our study, three patients were presenting 
